Mansoura university
Al Mansurah, 35511, Egypt
NCT Number: NCT04452682
This is a retrospective analytical study conducted at Vascular and Endovascular surgery Department, Mansoura University Hospital, including all patients admitted at the two periods first six months of 2019 and 2020.To demonstrate the effect of COVID-19 pandemic on the practice of emergency vascular surgery and critical limb threatening ischemia interventions by comparison two periods first six months of 2019 and 2020.
Looking for future studies?
Notify MeObservational
Al Mansurah, 35511, Egypt
INTRODUCTION:
The novel coronavirus pneumonia (COVID-19) pandemic has affected the globe, with Italy leading many reports of the incidence and mortalities. Recently reported studies have described the clinical characteristics and overall outcomes of patients with COVID-19 and the effects of treating these patients on the healthcare system.Two studies have reported associated coagulopathy disorders. These reports have highlighted the presence of a coexisting hypercoagulable state in patients with COVID-19, which might be associated with higher mortality.
The COVID-19 pandemic has had many impacts, both seen and unforeseen, all over the world. As expected, elective endovascular procedures have been halted, with a significant decrease in urgent/emergent procedures. This could reflect an understandable unwillingness on the part of patients who continue to self-isolate at home to come in for treatments, including those with Critical limb threatening ischemia. Also impacts on the supply chain side of performing interventions, had been reported, it is challenging to be in the middle of a complex CLTI (Critical limb threatening ischemia) case and request a routine device only to find out it is unavailable.
Aim of the work Evaluation the impact of COVID-19 pandemic on emergency vascular practice and critical limb ischemia.
Outcome
Primary outcomes:
Secondary outcomes:
Patients and methods Study location: The study will be conducted at the department of vascular surgery in Mansoura university hospitals Type of study: Observational analytical study Study duration: 2019-2020 Sample size: It will include all patients presented to our department at the first 6 months of 2019 and first 6 months of 2020. sample size will be 140-400 patients Inclusion criteria: all patients admitted to our department at that periods Exclusion criteria
Data collection:
Statistical analysis
· The data will be analyzed using Statistical Package for the Social Sciences. The numerical outcomes e.g. age is calculated as median. Gender will be recorded as frequency and percentage. Chi Square test is applied to assess the association of various parameters. The results will be considered statistically significant if the p-value is found to be less than or equal to 0.05. To assess possible risk factors for mortality, univariate analyses will be completed initially to aid in determining the variables that should be included in a stepwise logistic regression model.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The impact of COVID-19 pandemic on Critical limb threatening ischemia and emergency vascular practice
Time frame: 6 months
The ICU admission caused by Pneumonia proved radio-logically at both periods
Time frame: 6 months
percentage of different diagnoses at both periods
Time frame: 6 months
Mortality percentages at both periods
Mansoura University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06821139
COVID, COVID - 19
Surrey, British Columbia, Canada
View Trial DetailsNCT03590327
Apathy, COVID
Little Rock, Arkansas, United States
View Trial DetailsNCT04447833
ARDS, Human, COVID
Uppsala, Sweden
View Trial DetailsNCT04367545
COVID, RT-ddPCR Multiplex
Rouen, France
View Trial Details